Over the years several drugs have been tested for the treatment of canine Cushing’s syndrome. Mitotane is an adrenolytic drug that is very effective but not very “wieldy“, it was the drug most widely used in the past. For more than 10 years it has being available trilostane, an enzyme inhibitor which has been demonstrated to be effective in the treatment of this endocrinopathy and it is officially approved for the treatment of canine hypercortisolism. In this review the therapeutic approach to canine Cushing’s syndrome with particular
Sara, C., Eleonora, G.M.M., Federico Fracassi (2014). Terapia medica della Sindrome di Cushing nel cane. VETERINARIA, 28, 15-24.
Terapia medica della Sindrome di Cushing nel cane
CORRADINI, SARA;MALERBA, ELEONORA GLENDA MARIA;FRACASSI, FEDERICO
2014
Abstract
Over the years several drugs have been tested for the treatment of canine Cushing’s syndrome. Mitotane is an adrenolytic drug that is very effective but not very “wieldy“, it was the drug most widely used in the past. For more than 10 years it has being available trilostane, an enzyme inhibitor which has been demonstrated to be effective in the treatment of this endocrinopathy and it is officially approved for the treatment of canine hypercortisolism. In this review the therapeutic approach to canine Cushing’s syndrome with particularI documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
